Roles of lncRNA MAGI2-AS3 in human cancers

  • Liu Kai-xing
  • , Cheng Cheng
  • , Li Rui
  • , Shi Zheng-wei
  • , Tan Wen-wen
  • , Xu Peng

Research output: Contribution to journalReview articlepeer-review

31 Scopus citations

Abstract

Long noncoding RNAs (lncRNAs) are noncoding RNAs more than 200 nucleotides in length. A growing number of reports indicate that lncRNAs play a key role in multiple cancers by serving as oncogenes or tumor suppressor genes. MAGI2 antisense RNA 3 (MAGI2-AS3) is ubiquitously expressed in human cancers, and the level of MAGI2-AS3 expression is associated with the progression and prognosis of cancers. Moreover, dysregulation of MAGI2-AS3 has been found to regulate cancer cell proliferation, cell death, invasion and metastasis and treatment resistance by serving as a competing endogenous RNA (ceRNA), epigenomic regulator, and transcriptional regulator. Moreover, increasing evidence shows that MAGI2-AS3 may be a potential biomarker for cancer prognosis and a potential target for cancer therapy. In this review, we summarize current research on the functions, mechanisms and clinical significance of the lncRNA MAGI2-AS3 in cancer development.

Original languageEnglish
Article number111812
JournalBiomedicine and Pharmacotherapy
Volume141
DOIs
StatePublished - Sep 2021

Keywords

  • Biomarker
  • Long noncoding RNAs
  • MAGI2-AS3
  • Target

Fingerprint

Dive into the research topics of 'Roles of lncRNA MAGI2-AS3 in human cancers'. Together they form a unique fingerprint.

Cite this